Pacific Biosciences of California Inc
NASDAQ:PACB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
F
|
Fomento de Construcciones y Contratas SA
SWB:FCC
|
ES |
|
X
|
Xenon Pharmaceuticals Inc
SWB:XP0
|
CA |
|
H
|
Hess Corp
XMUN:AHC
|
US |
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
US |
|
D
|
Deterra Royalties Ltd
OTC:DETRF
|
AU |
|
La Francaise de l Energie SA
OTC:FDENF
|
FR |
Wall St Price Targets
PACB Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PACB's stock price target?
Price Target
2.51
USD
According to Wall Street analysts, the average 1-year price target for PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 28%.
